Sign In
Buy NVAX
$10.20
-0.0100 (-0.0979%)
At Close: Jun 03, 2026
Australia news live update: Novavax vaccine to roll out February; Victoria records 17 Covid deaths, NSW 24; Hunt suggests reseller hoarding a factor in rapid test shortage
12:12am, Monday, 24'th Jan 2022 The Guardian
Follow all the days news
Novavax Covid vaccine will be available for use in Australia in February, Greg Hunt says video
11:28pm, Sunday, 23'rd Jan 2022 The Guardian
Atagi has recommended the use of the Novavax vaccine
1 Green Flag for Novavax in 2022, and 1 Red Flag
11:00am, Sunday, 23'rd Jan 2022 The Motley Fool
The company has reached the coronavirus vaccine finish line.
Worldwide Adoption of Novavax Vaccines Makes It a Winner
07:42pm, Friday, 21'st Jan 2022 InvestorPlace
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Novavax can still generate billions of dollars of revenue per year from its shot, making NVAX stock quite attractive at its current levels. The post Worldwide Adoption of Novavax Vaccines Makes It a Winner appeared first on InvestorPlace . More From InvestorPlace Stock Prodigy Who Found NIO at $2 Says Buy THIS Now Man Who Called Black Monday: Prepare Now. #1 EV Stock Still Flying Under the Radar Interested in Crypto? Read This First
Novavax Stock is in a Tough Spot, but its Fortunes Could Improve
10:14pm, Thursday, 20'th Jan 2022 InvestorPlace
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Once the vaccine maker starts booking big sales internationally, NVAX stock could make a trip back to much higher prices. The post Novavax Stock is in a Tough Spot, but its Fortunes Could Improve appeared first on InvestorPlace . More From InvestorPlace Stock Prodigy Who Found NIO at $2 Says Buy THIS Now Man Who Called Black Monday: Prepare Now. #1 EV Stock Still Flying Under the Radar Interested in Crypto? Read This First
Why BioNTech, Moderna, Novavax, and Ocugen Stocks Are Plunging This Week
09:35pm, Thursday, 20'th Jan 2022 The Motley Fool
Several factors are dragging down these vaccine stocks.
Novavax Is Oversold, Time To Buy for Future Growth
09:32pm, Thursday, 20'th Jan 2022 InvestorPlace
InvestorPlace - Stock Market News, Stock Advice & Trading Tips NVAX stock seems oversold. Focus on low-income countries is likely to deliver revenue and cash flows from covid-19 vaccine sales in 2022. The post Novavax Is Oversold, Time To Buy for Future Growth appeared first on InvestorPlace . More From InvestorPlace Stock Prodigy Who Found NIO at $2 Says Buy THIS Now Man Who Called Black Monday: Prepare Now. #1 EV Stock Still Flying Under the Radar Interested in Crypto? Read This First
Novavax''s Long-Term Prospects Are Questionable
01:57pm, Thursday, 20'th Jan 2022 Seeking Alpha
Hot Stocks: AAL, UAL, TRV earnings; NVAX gets Australian approval; AMD downgrade
01:44pm, Thursday, 20'th Jan 2022 Seeking Alpha
AAL and UAL move in opposite directions on earnings news. TRV climbed following its quarterly results. NVAX received Australian approval for its COVID vaccine. AMD slipped on a downgrade.
Australia greenlights Novavax coronavirus vaccine, fifth in nation
05:46am, Thursday, 20'th Jan 2022 Business Standard
Novavax''s Covid-19 vaccine on Thursday became the fifth coronavirus vaccine approved for use in Australia.
Novavax becomes Australia''s 5th approved COVID-19 vaccine
04:39am, Thursday, 20'th Jan 2022 ABC News
Novavax''s COVID-19 vaccine has become the fifth coronavirus vaccine approved for use in Australia
Australia news live update: 25 Covid deaths in NSW; 15 in Victoria; TGA approves Novavax vaccine and two oral treatments; national cabinet meets
11:49pm, Wednesday, 19'th Jan 2022 The Guardian
Follow all the days news
Why Moderna, Pfizer, BioNTech And Novavax Shares Are Falling Today
04:17pm, Tuesday, 18'th Jan 2022 Benzinga
Shares of vaccine makers, including Moderna Inc Full story available on Benzinga.com
Novavax could have significant impact on vax rate
10:00am, Tuesday, 18'th Jan 2022 Herald Sun Australia
This coronavirus article is unlocked and free to read in the interest of community health and safety. Tap here to see the latest great value offer for full digital access to trusted news from the Herald Sun and Leader.
What Will It Take for Novavax Stock to Rebound?
12:01pm, Sunday, 16'th Jan 2022 The Motley Fool
The vaccine maker''s positive news in recent weeks hasn''t been enough to satisfy investors.
